Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses

Journal of Inherited Metabolic Disease

Volumn 28, Issue 5, 2005, Pages 743-757

  Tomatsu, S ^a   Gutierrez, M A ^a,f   Ishimaru, T ^b   Pena O M ^a   Montano A M ^a   Maeda, H ^b   Velez Castrillon, S ^a   Nishioka, T ^a   Fachel, A A ^d   Cooper, A ^e   Thornley, M ^e   Wraith, E ^e   Barrera, L A ^f   Laybauer, L S ^d   Giugliani, R ^d   Schwartz, I V ^d   Frenking, G Schulze ^g   Beck, M ^g   Kircher, S G ^h   Paschke, E ⁱ   Yamaguchi, S ^c   Ullrich, K ^j   Isogai, K ^k   Suzuki, Y ^k   Orii, T ^k   Noguchi, A ^a   more..

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SEIKAGAKU CORPORATION   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^f PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

^h UNIVERSITY OF VIENNA   (Austria)

ⁱ UNIVERSITY OF GRAZ   (Austria)

^j UNIVERSITY OF HAMBURG   (Germany)

^k GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMURIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; INFANT; MAJOR CLINICAL STUDY; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 2; MUCOLIPIDOSIS TYPE 3; MUCOPOLYSACCHARIDOSIS; MUCOPOLYSACCHARIDOSIS TYPE 7; SANFILIPPO SYNDROME;

ADOLESCENT; BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSAMINOGLYCANS; HEPARIN; HEPARITIN SULFATE; HUMANS; INFANT; INFANT, NEWBORN; MUCOLIPIDOSES; MUCOPOLYSACCHARIDOSES;

EID: 25144486704     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-005-0069-y     Document Type: Article

References (23)

1. Byers S, Rozaklis T, Brumfield LK, Ranieri E, Hopwood JJ (1998) Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: Characterization and basis of a diagnostic test for MPS. Mol Genet Metab 65: 282-290. 10.1006/mgme.1998.2761
2. Crawley AC, Niedzielski KH, Isaac EL, Davey RC, Byers S, Hopwood JJ (1997) Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. J Clin Invest 99: 651-662. 9045867
3. David G (1993) Integral membrane heparan sulfate proteoglycans. FASEB J 7: 1023-1030. 8370471
4. Fuller M, Meikle PJ, Hopwood JJ (2004) Glycosaminoglycan degradation fragments in mucopolysaccharidosis I. Glycobiology 14: 443-450. 10.1093/ glycob/cwh049
5. Harmatz P, Whitley CB, Waber L, et al (2004) Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr 144: 574-580. 10.1016/j.jpeds.2004.03.018
6. Kakkis ED, Muenzer J, Tiller GE, et al (2001) Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 344: 182-188. 10.1056/ NEJM200101183440304
7. Kornfeld S, Sly WS (2001) I-cell disease and pseudo-Hurler polydystrophy: Disorders of lysosomal enzyme phosphorylation and localization. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3469-3482.
8. Leteux C, Chai W, Nagai K, et al (2001) 10E4 antigen of scrapie lesions contains an unusual nonsulfated heparan motif. J Biol Chem 276: 12539-12545. 10.1074/jbc.M010291200
9. Lindahl U, Kusche-Gullberg M, Kjellen L (1998) Regulated diversity of heparan sulfate. J Biol Chem 273: 24979-24982. 10.1074/jbc.273.39.24979
10. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249-254. 10.1001/jama.281.3.249
11. Meikle PJ, Ranieri ER, Simonsen H, et al (2004) Newborn screening for lysosomal storage disorders: Clinical evaluation of a two-tier strategy. Pediatrics 114 (4): 909-916. 10.1542/peds.2004-0583
12. Muenzer J, Fisher A (2004) Advances in the treatment of mucopolysaccharidosis type I. N Engl J Med 350: 1932-1934. 10.1056/ NEJMp048084
13. Muenzer J, Lamsa JC, Garcia A, et al (2002) Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): A preliminary report. Acta Paediatr Suppl 439: 98-99. 10.1080/080352502762458012
14. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3421-3452
15. Oguma T, Toyoda H, Toida T, Imanari T (2001) Analytical method of chondroitin/dermatan sulfates using high performance liquid chromatography/turbo ionspray ionization mass spectrometry: Application to analyses of the tumor tissue sections on glass slides. Biomed Chromatogr 15: 356-362. 10.1002/bmc.74
16. Ramsay SL, Meikle PJ, Hopwood JJ (2003) Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry. Mol Genet Metab 78: 193-204. 10.1016/ S1096-7192(03)00018-0
17. Tomatsu S, Okamura K, Taketani T, et al (2004) Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA. Pediatr Res 55: 592-597. 10.1203/01.PDR.0000113767.60140.E9
18. Van den Born J, Gunnarsson K, Bakker MAH, et al (1995) Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 270: 31303-31309. 10.1074/ jbc.270.52.31303
19. Wiesmann UN, Spycher MA, Meier C, Liebaers I, Herschkowitz N (1980) Prenatal mucopolysaccharidosis II (Hunter): A pathogenetic study. Pediatr Res 14: 749-756. 6770331
20. Wraith EJ, Clarke LA, Beck M, et al (2004) Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double blinded, placebo-controlled, multinational study of recombinant human α-l-iduronidase (laronidase). J Pediatr 144: 581-588 10.1016/ j.jpeds.2004.01.046
21. Wraith EJ, Hopwood JJ, Fuller M, et al (2005) Laronidase treatment of mucopolysaccharidosis I. BioDrugs 19: 1-7. 15691212
22. Yanagishita M, Hascall VC (1992) Cell surface heparan sulfate proteoglycans. J Biol Chem 267: 9451-9454. 1577788
23. Yoshida K, Miyauchi S, Kikuchi H, Tawada A, Tokuyasu K (1989) Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography. Anal Biochem 177: 327-332. 10.1016/0003-2697(89)90061-4